Integrum B net sales rise 27% YoY to SEK 30.2 million
Integrum AB Class B reports net sales up 27% year-over-year to SEK 30.2 million. S1 surgeries increased 17% and the company achieved positive EBITDA, citing digital and bionics investment plus cost reductions.
Net sales grew 27% year-over-year to SEK 30.2 million, with S1 surgeries up 17% and positive EBITDA achieved.
Strategic investments in digital platforms and bionics, along with cost reductions, drove improved profitability and scalability.Original document: Integrum AB Class B [INTEG_B] Interim rep…